Real-Time EEG Suppression Detection Using Derivative Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current automated methods for detecting suppression periods in electroencephalographic (EEG) signals are prone to noise and artifacts, leading to inaccurate detection and are time-consuming and subjective, requiring expert training.
Innovation Solution
An automated system that computes the first derivative of EEG signals in real-time, using suppression detection parameters like median absolute value and artifact removal algorithms to accurately identify suppression periods, even in noisy conditions, and provides real-time feedback and control options for clinicians.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If visual inspection by trained experts is used to detect suppression periods, then detection accuracy is improved, but time consumption and cost increase
Solution Approach 1:
The system enables automated detection of suppression periods using computer algorithms that process EEG signals independently, eliminating the need for continuous expert review. The algorithm calculates suppression ratio by analyzing amplitude thresholds and duration criteria automatically, allowing the system to serve itself without requiring trained personnel for each detection task.
Solution Approach 2:
The patent replaces the manual visual inspection mechanism with an automated computational system. The mechanical process of expert observation and subjective judgment is substituted with algorithmic processing that objectively measures EEG signal characteristics, thereby reducing time consumption while maintaining detection accuracy.
2Loss of time
If automated peak-to-peak measurement methods are used for suppression detection, then time consumption is reduced, but detection reliability deteriorates due to sensitivity to noise and artifacts
Solution Approach 1:
The system changes the measurement parameter from simple peak-to-peak amplitude to a more robust suppression ratio calculation that considers multiple factors including amplitude thresholds, duration criteria, and signal quality metrics. This parameter transformation makes the detection less sensitive to transient noise and artifacts while maintaining automation benefits.
Solution Approach 2:
The system incorporates feedback mechanisms that continuously monitor signal quality and adjust detection parameters accordingly. By analyzing the reliability of measured parameters and comparing them against expected physiological ranges, the system can identify and discard measurements corrupted by artifacts, thereby improving overall detection reliability.
3Device complexity
If simple amplitude thresholding is used for automated detection, then device complexity is reduced, but measurement precision deteriorates due to subjectivity and noise sensitivity
Solution Approach 1:
The detection algorithm is segmented into distinct functional modules: signal acquisition, preprocessing, threshold evaluation, duration measurement, and suppression ratio calculation. This modular structure maintains relative simplicity while improving precision by allowing each segment to be optimized independently and reducing cross-interference between detection stages.
Data Source
AI summary
The present invention relates to a physiological monitor and system, more particularly to an electroencephalogram (EEG) monitor and system, and a method of detecting the presence or occurrence of suppression in the EEG signal. Accurately detecting signal suppression in real-time provides the clinician with the ability to prevent possibly severe, long-term damage to patients as a result of excessive anesthetic or sedative. The present invention provides such a system and method for accurately and automatically detecting suppression in physiological, particularly EEG, signals in real-time and allowing for the administration of treatment or medication to reverse the effects of such situations, or minimize the harm caused. The present invention also allows for the use of closed-loop treatment or drug delivery systems to further automate the process and provide rapid treatment to a patient to reverse or minimize potential harm.